Answers are grounded in this paper and cite their sources.
Investigates cognitive decline in AQP4+NMOSD, suggesting new diagnostic and treatment approaches.
Subacute cognitive decline and imbalance in aquaporin-4-antibody-seropositive neuromyelitis optica spectrum disorder (AQP4+NMOSD) treated with mycophenolate has a broad differential diagnosis, including cerebral involvement of AQP4+NMOSD, infections, or other complications of immunosuppression. In this article, we highlight the diagnostic and treatment approach in a patient with AQP4+NMOSD who developed multifocal brain lesions.
No takes yet. Share an insight, caveat, or question.
Ajwani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: